RNAC vs WY · P/E 2.1, rev $78.0K vs P/E 43, rev $3.59B
Cartesian Therapeutics Inc. (RNAC) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported RNAC revenue for 2026-06-30 was $78.0K. Net income was -$23.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
RNAC currently screens at market cap $290.9M and trailing P/E 2.1. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the RNAC and WY stock pages for the full models.
Not investment advice.